Highlights from MDS and Nonmalignant Hematology - New drugs for MDS: Rigosertib, Luspatercept, Ibrutnib

Kanwarpal Kahlon, MD, from Ronald Reagan UCLA Medical Center talks about the highlights from Myelodysplastic Syndrome (MDS) and nonmalignant hematology and also new drugs for MDS: Rigosertib, Luspater... Author: moasc Added: 02/01/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts